KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Incyte (INCY) over the last 16 years, with Q3 2025 value amounting to -$12.2 million.

  • Incyte's Gains from Investment Securities fell 15213.16% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.3 million, marking a year-over-year decrease of 4062.82%. This contributed to the annual value of $373.1 million for FY2024, which is 136.17% down from last year.
  • Incyte's Gains from Investment Securities amounted to -$12.2 million in Q3 2025, which was down 15213.16% from $22.8 million recorded in Q2 2025.
  • Incyte's 5-year Gains from Investment Securities high stood at $125.0 million for Q4 2023, and its period low was -$21.9 million during Q3 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was $8.4 million (2023), whereas its average is $16.8 million.
  • As far as peak fluctuations go, Incyte's Gains from Investment Securities crashed by 31011.28% in 2022, and later soared by 559530.52% in 2024.
  • Incyte's Gains from Investment Securities (Quarter) stood at $21.9 million in 2021, then fell by 9.85% to $19.7 million in 2022, then skyrocketed by 534.49% to $125.0 million in 2023, then plummeted by 43.85% to $70.2 million in 2024, then crashed by 117.39% to -$12.2 million in 2025.
  • Its Gains from Investment Securities stands at -$12.2 million for Q3 2025, versus $22.8 million for Q2 2025 and $11.6 million for Q1 2025.